NCT06656572View on ClinicalTrials.gov

Immunogenomic Analyses of Pediatric Catatonia

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2030

Conditions
Catatonia
Interventions
GENETIC

Genetic: Genomic sequencing and molecular diagnostic results, if any.

Genomic sequencing results may be used for diagnosis and treatment of participants.

DIAGNOSTIC_TEST

Phage display ImmunoPrecipiation Sequencing (PhIP-Seq)

Whole Proteome programmable phage display immunoprecipitation sequencing will be used to diagnose known and novel autoantibodies.

Sponsors
All Listed Sponsors
collaborator

Brain & Behavior Research Foundation

OTHER

lead

Rady Pediatric Genomics & Systems Medicine Institute

OTHER